Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Si-Bone (SIBN) over the last 9 years, with Q3 2025 value amounting to -$28000.0.

  • Si-Bone's Other Non Operating Income fell 56666.67% to -$28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$14000.0, marking a year-over-year decrease of 11372.55%. This contributed to the annual value of -$73000.0 for FY2024, which is 15177.3% down from last year.
  • Si-Bone's Other Non Operating Income amounted to -$28000.0 in Q3 2025, which was down 56666.67% from -$2000.0 recorded in Q2 2025.
  • In the past 5 years, Si-Bone's Other Non Operating Income registered a high of $336000.0 during Q1 2021, and its lowest value of -$183000.0 during Q3 2022.
  • Moreover, its 5-year median value for Other Non Operating Income was $4000.0 (2024), whereas its average is $9947.4.
  • The largest annual percentage gain for Si-Bone's Other Non Operating Income in the last 5 years was 203076.92% (2022), contrasted with its biggest fall of 122307.69% (2022).
  • Si-Bone's Other Non Operating Income (Quarter) stood at -$13000.0 in 2021, then skyrocketed by 2030.77% to $251000.0 in 2022, then dropped by 26.29% to $185000.0 in 2023, then plummeted by 95.68% to $8000.0 in 2024, then plummeted by 450.0% to -$28000.0 in 2025.
  • Its Other Non Operating Income stands at -$28000.0 for Q3 2025, versus -$2000.0 for Q2 2025 and $8000.0 for Q1 2025.